On 1 April 2018, Mariam Plc granted 500 share appreciation rights (SARs) to its 300 employees. All of the rights vested on 31 March 2020 can be exercised from 1 April 2020 up to 31 March 2022. At the grant date, the value of each SAR was GH10, and it was estimated that 5% of the employees would leave during the vesting period. The fair value of the SARs is as follows: Date Fair Value 31 March 2019 GH9 31 March 2020 GH11 31 March 2021 GH12

All the employees who were expected to leave the employment did leave the company as expected before 31 March 2020. On 31 March 2021, 60 employees exercised their options when the intrinsic value of the right was GH10.50 and was paid in cash. Mariam Plc is, however, confused as to whether to account for the SARs under IFRS 2: Share-based Payment or IFRS 13: Fair Value Measurement and would like to be advised as to how the SARs should have been accounted for from the grant date to 31 March 2021. Required: Advise Mariam Plc on how the above transactions should be accounted for in its financial statements with reference to relevant International Financial Reporting Standards (IFRS).